MeSH term
Count | 1-Methyl-3-isobutylxanthine/*pharmacology | 4 |
1-Methyl-3-isobutylxanthine/pharmacology | 95 |
1-Methyl-3-isobutylxanthine/metabolism/pharmacology | 1 |
1-Methyl-3-isobutylxanthine/*chemistry/*metabolism/pharmacology | 1 |
1-Methyl-3-isobutylxanthine | 2 |
1-Methyl-3-isobutylxanthine/metabolism | 2 |
1-Methyl-3-isobutylxanthine/chemistry | 1 |
1-Methyl-4-phenylpyridinium/pharmacology | 8 |
Methyl Ethers/pharmacology | 1 |
Methyl Green/pharmacology | 1 |
Methyl Ethers/*pharmacology | 2 |
N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology | 1 |
Methyl Methanesulfonate/*pharmacology | 5 |
1-Methyl-4-phenylpyridinium/*pharmacology | 1 |
Methyl Methanesulfonate/pharmacology | 40 |
N-Methyl-3,4-methylenedioxyamphetamine/blood/*pharmacology | 1 |
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide/*pharmacology | 1 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology | 4 |
Tosylarginine Methyl Ester/pharmacology | 2 |
NG-Nitroarginine Methyl Ester/pharmacology | 49 |
Tosylarginine Methyl Ester/*pharmacology | 1 |
2-Methyl-4-chlorophenoxyacetic Acid/*pharmacology | 1 |
NG-Nitroarginine Methyl Ester/*pharmacology | 2 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*pharmacology | 7 |
Methyl Methanesulfonate/analogs & derivatives/pharmacology | 2 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/metabolism/*pharmacology | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology | 4 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*pharmacology | 1 |
Methyl Methanesulfonate | 5 |
*Methyl Ethers | 2 |
N-Methyl-3,4-methylenedioxyamphetamine | 2 |
Methyl Green | 1 |
1-Methyl-4-phenylpyridinium/*toxicity | 2 |
N-Methyl-3,4-methylenedioxyamphetamine/*toxicity | 1 |
Tosylarginine Methyl Ester | 1 |
1-Methyl-4-phenylpyridinium/metabolism | 1 |
N-Methyl-3,4-methylenedioxyamphetamine/*metabolism | 1 |
Methyl Parathion/toxicity | 1 |
Methyl Ethers/*analysis | 1 |
*Methyl Ethers/pharmacokinetics | 1 |
Methyl Ethers/*metabolism | 2 |
1-Methyl-4-phenylpyridinium/chemistry | 1 |
N-Methyl-3,4-methylenedioxyamphetamine/toxicity | 1 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 7 |
1-Methyl-4-phenylpyridinium/poisoning | 1 |
1-Methyl-4-phenylpyridinium/pharmacokinetics | 1 |
Methyl Methanesulfonate/*toxicity | 2 |
Methyl Methanesulfonate/toxicity | 8 |
Receptors, N-Methyl-D-Aspartate | 1 |
1-Methyl-4-phenylpyridinium/toxicity | 3 |
Methyl Chloride/blood | 1 |
Methyl Methanesulfonate/*metabolism | 1 |
Methyl Chloride/*blood | 1 |
Methyl Methanesulfonate/chemistry | 1 |
Methyl Ethers/*toxicity | 1 |
NG-Nitroarginine Methyl Ester | 11 |
Receptors, N-Methyl-D-Aspartate/*physiology | 6 |
N-Methyl-3,4-methylenedioxyamphetamine/pharmacokinetics/*toxicity | 1 |
1-Methyl-4-phenylpyridinium/*antagonists & inhibitors | 1 |
Receptors, N-Methyl-D-Aspartate/*analysis | 1 |
Methyl Ethers/*adverse effects | 1 |
Receptors, N-Methyl-D-Aspartate/genetics | 4 |
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 16 |
N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects | 1 |
Receptors, N-Methyl-D-Aspartate/agonists | 1 |
Receptors, N-Methyl-D-Aspartate/analysis | 1 |
Methyl Ethers/*metabolism/pharmacokinetics | 1 |
Methyl Parathion/adverse effects | 1 |
Receptors, N-Methyl-D-Aspartate/metabolism | 17 |
Receptors, N-Methyl-D-Aspartate/physiology | 11 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*chemistry | 1 |
Receptors, N-Methyl-D-Aspartate/*metabolism | 11 |
Methyl Ethers/*administration & dosage | 1 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*metabolism | 1 |
Receptors, N-Methyl-D-Aspartate/*genetics | 25 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/metabolism | 1 |
Methyl n-Butyl Ketone/*toxicity | 1 |
Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors | 6 |
Receptors, N-Methyl-D-Aspartate/*biosynthesis/genetics | 1 |
Receptors, N-Methyl-D-Aspartate/biosynthesis/physiology | 1 |
Receptors, N-Methyl-D-Aspartate/metabolism/*physiology | 1 |
Receptors, N-Methyl-D-Aspartate/genetics/metabolism | 2 |
Receptors, N-Methyl-D-Aspartate/*analysis/chemistry | 1 |
NG-Nitroarginine Methyl Ester/administration & dosage | 1 |
N-Methyl-3,4-methylenedioxyamphetamine/chemistry/*metabolism/*toxicity | 1 |
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)/*genetics | 1 |
Receptors, N-Methyl-D-Aspartate/analysis/genetics | 1 |
Receptors, N-Methyl-D-Aspartate/genetics/*metabolism | 3 |
Receptors, N-Methyl-D-Aspartate/*chemistry/*physiology | 1 |
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)/immunology | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic | 1 |
1-Methyl-4-phenylpyridinium/antagonists & inhibitors/*toxicity | 1 |
Receptors, N-Methyl-D-Aspartate/classification/*genetics | 1 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*administration & dosage | 1 |
Receptors, N-Methyl-D-Aspartate/*chemistry/metabolism | 1 |
Receptors, N-Methyl-D-Aspartate/*metabolism/physiology | 1 |
Receptors, N-Methyl-D-Aspartate/*genetics/*metabolism | 2 |
Receptors, N-Methyl-D-Aspartate/*genetics/metabolism | 1 |
Receptors, N-Methyl-D-Aspartate/genetics/physiology | 1 |
Receptors, N-Methyl-D-Aspartate/chemistry/*genetics | 3 |
